Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas.

MLA

Sharma, Shivani, et al. “Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas.” South Asian Journal of Cancer, vol. 11, no. 3, July 2022, pp. 249–55. EBSCOhost, https://doi.org/10.1055/s-0042-1750187.

APA

Sharma, S., Mishra, S. K., Bhardwaj, M., Jha, S., Geller, M., Dewan, A., Jain, E., Dixit, M., Jain, D., Munjal, G., Kumar, S., & Mohanty, S. K. (2022). Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas. South Asian Journal of Cancer, 11(3), 249–255. https://doi.org/10.1055/s-0042-1750187

Chicago

Sharma, Shivani, Sourav K. Mishra, Mohit Bhardwaj, Shilpy Jha, Matthew Geller, Aditi Dewan, Ekta Jain, et al. 2022. “Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 Fluorescence In Situ Hybridization Assay in a Contemporary Cohort of Pulmonary Adenocarcinomas.” South Asian Journal of Cancer 11 (3): 249–55. doi:10.1055/s-0042-1750187.